Aim
There are few types of drugs that can be used in the active phase of
Peyronie’s disease. Methylprednisolone is a corticosteroid with a strong
anti-inflammatory effect. In this study, we aimed to evaluate the effect
of intralesional low dose methylprednisolone treatment on patients in
the active phase of Peyronie’s disease.